Rephonic
Artwork for OncLive® On Air

OncLive® On Air

OncLive® On Air
Small Cell Lung Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Immunotherapy
Multiple Myeloma
Clinical Trials
Chronic Myeloid Leukemia
Triple Negative Breast Cancer
Antibody Drug Conjugates
Oncology
Hr-Positive Her2-Negative Metastatic Breast Cancer
Pembrolizumab
Biomarker Testing
ESR1 Mutations
Bladder Cancer
Triple-Negative Breast Cancer
Prostate Cancer
Tyrosine Kinase Inhibitors
Her2-Positive Breast Cancer
KRAS

In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers,... more

PublishesDailyEpisodes500Founded8 years ago
Number of ListenersCategories
Health & FitnessScience

Listen to this Podcast

Artwork for OncLive® On Air

Latest Episodes

Welcome to OncLive On Air®! I’m your host today, Chris Ryan.

OncLive On Air is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print fo... more

In this episode of Oncology Unplugged, Chandler Park, MD, MSc, FACP, of Norton Cancer Institute in Louisville, Kentucky, spoke with Tejas Patil, MD, an assistant professor of medicine and vice head of Clinical Affairs in the Division of Medical Oncol... more

Two Onc Docs, hosted by Samantha A. Armstrong, MD, and Karine Tawagi, MD, is a podcast dedicated to providing current and future oncologists and hematologists with the knowledge they need to ace their boards and deliver quality patient care. Dr Armst... more

In today's episode, we spoke with Zev A. Wainberg, MD, MSc, about subgroup data from the phase 3 RASolute 302 trial (NCT06625320) of daraxonrasib (Rasonque) in patients with previously treated metastatic pancreatic cancer, which were presented at the... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Noa Biran
Medical director of Clinical Protocol Data Management and associate professor of medicine in the Multiple Myeloma Division
John Theurer Cancer Center
Episode: S19 Ep18: Unpacking Key Multiple Myeloma Data From ASCO 2026: With Noa Biran, MD
Petros Grivas
Medical oncologist and professor at Fred Hutch Cancer Center and the University of Washington School of Medicine
Fred Hutch Cancer Center
Episode: S19 Ep17: Perioperative Research Success Is Set to Transform Bladder Cancer Care After ESMO 2026
Fadi Haddad
Oncologist discussing CML treatment and TKI use
Episode: S19 Ep16: Thorough Treatment Adherence and Selection Anchor Proper TKI Utilization in CML
Nathan A. Boggs
Director of the Allergy Division at the Uniformed Services University of the Health Sciences
Uniformed Services University of the Health Sciences
Episode: S19 Ep15: How Allergists Fit Into the Systemic Mastocytosis Management Equation
David Carbone
Thoracic medical oncologist and director of the Thoracic Oncology Center at The Ohio State University
The Ohio State University
Episode: S19 Ep13: Beyond PD-L1: Refining First-Line Treatment Decisions in Metastatic NSCLC
Lyudmila Bazhenova
Thoracic medical oncologist and co-lead of the lung cancer team at UC San Diego Moores Cancer Center
UC San Diego Moores Cancer Center
Episode: S19 Ep12: Order Both IHC and NGS: Defining MET Alterations and Positioning Telisotuzumab Vedotin in Non–Small Cell Lung Cancer
Sandip Patel
Professor of medical oncology at UC San Diego
UC San Diego
Episode: S19 Ep12: Order Both IHC and NGS: Defining MET Alterations and Positioning Telisotuzumab Vedotin in Non–Small Cell Lung Cancer
Jacob Sands
Associate chief of the Lowe Center for Thoracic Oncology and oncology medical director of the International Patient Center
Dana-Farber Cancer Institute
Episode: S19 Ep11: Weigh Benefit Against Burden: Defining Lurbinectedin’s Role in a Shifting Small Cell Lung Cancer Landscape
Triparna Sen
Professor of internal medicine and director of the Lung Cancer Preclinical Therapeutics Platform
The Ohio State University Comprehensive Cancer Center
Episode: S19 Ep11: Weigh Benefit Against Burden: Defining Lurbinectedin’s Role in a Shifting Small Cell Lung Cancer Landscape

Hosts

Caroline Seymour
Oncology journalist and presenter
Aisling Wehner
Alex Bice
Senior content associate at Oncology Nursing News

Reviews

4.5 out of 5 stars from 34 ratings
  • Best option for CME podcasts

    Love the content! Easily the best platform for listening to CME and staying updated while on the go. Keep up the great work!

    Apple Podcasts
    5
    Dlshaka
    United Statesa year ago
  • My favorite podcast for oncology

    This podcast provides excellent information to anyone who works in the medical field on oncology.

    Apple Podcasts
    5
    Chiliman1986
    United States7 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

The format is appreciated as a convenient way to access continuing medical education.
The content is seen as useful to people working in oncology and the wider medical field.
Listeners value the clinical information for keeping up with oncology developments while on the go.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#170
South Korea/Health & Fitness
Apple Podcasts
#240
Hong Kong/Health & Fitness

Talking Points

Recent interactions between the hosts and their guests.

S19 Ep15: How Allergists Fit Into the Systemic Mastocytosis Management Equation
Q: With these two agents just looking at how they've shifted the treatment paradigm, what kind of impact have they had on the treatment and the management of these patients in clinic?
Boggs says avapritinib and newer targeted agents have moved care toward precision treatment. He describes promising trial results for bezuclastinib, including bone marrow responses and a favorable safety profile, and notes that elenestinib is being developed to avoid crossing the blood-brain barrier.
S19 Ep15: How Allergists Fit Into the Systemic Mastocytosis Management Equation
Q: When you are approaching a potential diagnosis, how do you differentiate between typical allergies versus something that may be tied to systemic mastocytosis? What kind of tests are you conducting to help you land on that answer?
Boggs identifies fixed pigmented skin lesions that urticate with stimulation and severe anaphylaxis as important clues. He says patients with these signs may be offered a bone marrow biopsy, followed by specialized molecular and immunohistochemical testing reviewed by a hematopathologist.
S19 Ep17: Perioperative Research Success Is Set to Transform Bladder Cancer Care After ESMO 2026
Q: Are we getting close to biology-driven treatment selection in muscle-invasive bladder cancer?
Grivas says molecular subtype and biomarker analyses are valuable but exploratory findings are difficult to validate for clinical use, especially with combination therapies. He sees circulating tumor DNA as closer to influencing treatment decisions, while noting that more evidence is needed.
S19 Ep17: Perioperative Research Success Is Set to Transform Bladder Cancer Care After ESMO 2026
Q: What do you think about the VOLGA study, and overall in terms of the top-line data?
Grivas describes VOLGA as a positive trial: durvalumab with enfortumab vedotin met event-free and overall survival endpoints, while adding tremelimumab met event-free survival but not overall survival. He says the need for adjuvant enfortumab vedotin remains unresolved.
S19 Ep16: Thorough Treatment Adherence and Selection Anchor Proper TKI Utilization in CML
Q: Are there any available alternative formulations of TKIs, and do they have advantages or limitations?
Haddad describes liquid and orally disintegrating formulations as possible options for patients who cannot swallow, some patients with advanced-phase CML or Philadelphia chromosome-positive acute lymphoblastic leukemia, and children. He says their benefits may be limited in routine practice, where oral tablets have worked well.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About OncLive® On Air

What is OncLive® On Air about and what kind of topics does it cover?

Clinical interviews with academic oncologists and other cancer-care experts focus on how research findings, trial results, and new treatment approvals shape practice. Discussions span solid tumors and hematologic malignancies, with recurring attention to targeted therapies, immunotherapy, antibody-drug conjugates, biomarkers, treatment sequencing, toxicity management, and practical care delivery. Some conversations also address board exam preparation and emerging clinical technologies.

Regular presenters include oncology journalist Caroline Seymour and hosts Aisling Wehner and Alex Bice, alongside clinicians who bring specialist perspectives to particular topics. Guests are commonly academic oncologists, clinical researchers, and other exp... more

Where can I find podcast stats for OncLive® On Air?

Rephonic provides a wide range of podcast stats for OncLive® On Air. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to OncLive® On Air and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does OncLive® On Air get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for OncLive® On Air, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for OncLive® On Air?

Rephonic provides comprehensive predictive audience data for OncLive® On Air, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does OncLive® On Air have?

To see how many followers or subscribers OncLive® On Air has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to OncLive® On Air?

These podcasts share a similar audience with OncLive® On Air:

1. Two Onc Docs
2. Oncology Brothers: Practice-Changing Cancer Discussions
3. Oncology Today with Dr Neil Love
4. Research To Practice | Oncology Videos
5. ASCO Daily News

How many episodes of OncLive® On Air are there?

OncLive® On Air launched 8 years ago and published 500 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact OncLive® On Air?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for OncLive® On Air?

Rephonic pulls ratings and reviews for OncLive® On Air from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for OncLive® On Air?

Rephonic provides full transcripts for episodes of OncLive® On Air. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on OncLive® On Air?

Recent guests on OncLive® On Air include:

1. Noa Biran
2. Petros Grivas
3. Fadi Haddad
4. Nathan A. Boggs
5. David Carbone
6. Lyudmila Bazhenova
7. Sandip Patel
8. Jacob Sands

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days